Indications |
Oral Chronic bronchospasm Adult: As hydrate: Initially, 225-450 mg bid, increased if necessary. Child: >3 yr: As modified-release hydrate: 12 mg/kg daily increased to 24 mg/kg daily in 2 divided doses after 1 wk. Elderly: Dose reduction may be ncessary. Hepatic impairment: Dose reduction may be ncessary. Intravenous Acute severe bronchospasm Adult: Loading dose: 5 mg/kg (ideal body weight) or 250-500 mg (25 mg/ml) by slow inj or infusion over 20-30 min. Maintenance infusion dose: 0.5 mg/kg/hr. Max rate: 25 mg/min. Child: Loading dose: same as adult dose. Maintenance dose: 6 mth-9 yr: 1 mg/kg/hr and 10-16 yr: 0.8 mg/kg/hr. Elderly: Dose reduction may be ncessary. Hepatic impairment: Dose reduction may be ncessary. Special Populations: Reduce maintenance dose in patients with cor pulmonale, heart failure or liver disease and in elderly. Increase maintenance dose for smokers. Incompatibility: Incompatible with metals. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Neonates, elderly, lactation, pregnancy, cardiac/hepatic diseases, peptic ulceration, hyperthyroidism, hypertension, epilepsy, heart failure, chronic alcoholism, acute febrile illness. |
Adverse Reactions |
Nausea, vomiting, abdominal pain, diarrhoea, headache, insomnia, dizziness, anxiety, restlessness; tremor, palpitations. Potentially Fatal: Convulsions, cardiac arrhythmias, hypotension and sudden death after too rapid IV injection. |
Overdose Reactions |
Symptoms may include agitated maniacal behavior, frequent vomiting, extreme thirst, slight fever, tinnitus, palpitation and arrhythmias. Treatment is usually supportive and withdrawal of the drug. Restoration of fluid and electrolyte balance is necessary. |
Drug Interactions |
Other xanthines. Clearance reduced by allopurinol, some antiarrhythmics, cimetidine, disulfiram, fluvoxamine, interferon-α, macrolide antibiotics, quinolones, oral contraceptives, thiabendazole and viloxazine. Clearance increased by phenytoin, anticonvulsants, ritonavir, rifampicin, sulfinpyrazone, cigarette smoking. Corticosteroids, diuretics, β2-agonists. Potentially Fatal: Increased risk of cardiac arrhythmias with sympathomimetics and halothane. Tachycardia with pancuronium. β-blockers inhibit metabolism. Increased risk of convulsion with quinolones, ketamine. See Below for More aminophylline Drug Interactions |
Food Interactions |
Rate of absorption reduced but not extent. |
Mechanism of Actions |
Aminophylline is a combination of theophylline and ethylenediamine. Ethylenediamine is inactive; it increases the solubility of theophylline in water. Theophylline relaxes bronchial smooth muscle. Suggested mechanisms are an increase in intracellular cAMP through inhibition of phosphodiesterase; adenosine receptor antagonism, prostaglandin antagonism and effects on intracellular calcium. Absorption: Rate of absorption delayed by food. Distribution: Crosses the placenta and enters breast milk. Metabolism: Undergoes hepatic metabolism. Excretion: Via urine. |
Administration |
Should be taken on an empty stomach. (Take on an empty stomach at least 1 hr before or 2 hr after meals.) |
Storage Conditions |
Intravenous: Store below 25°C. |
ATC Classification |
R03DA05 - aminophylline ; Belongs to the class of xanthines. Used in the systemic treatment of obstructive airway diseases. |
Storage |
Intravenous: Store below 25°C. |
Available As |
|
Aminophylline
Post Review about Aminophylline Click here to cancel reply.
Aminophylline Containing Brands
Aminophylline is used in following diseases
Drug - Drug Interactions of Aminophylline
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.